Table of Contents
Scope and Themes
-
- What you need to know
- Definition
- Data for this report
- Abbreviations and terms
- Abbreviations
- Terms
Executive Summary, Part I: Market Wide Issues
-
- Access to healthcare the primary obstacle to increased sales
- Consumers losing faith in pharmaceutical companies
- OTC and Rx medication increasingly competitive
- Attentiveness to advertising dependent on prevalence of condition
- Younger respondents more attentive, but less able to receive prescriptions
- Consumers more active in researching conditions and treatments
- Selling the branded product when generics are available
Fast Forward Trends
-
- Consumer as King
- Change in consumer sentiment
- Changes in healthcare
- Source[s] of Authority
- Partnership with the People
Healthcare Coverage
-
- Introduction
- Access to healthcare coverage
-
- Figure 1: Access to health insurance, November 2007, and May 2006-June 2007
-
- Figure 2: Rx prevalence of usage, by type of medical insurance, November 2007
Distrust of Pharmaceutical Companies
-
- Consumer distrust of pharmaceutical companies
-
- Figure 3: Attitudes toward prescription medicine, by availability of medical insurance, November 2007
- Trust for pharmaceutical ads by age
-
- Figure 4: Attitudes regarding trust and pharmaceutical companies, by age, November 2007
- Doctors reject pharmaceutical sales tactics
- Consumer attitudes toward their doctors
-
- Figure 5: Attitudes towards doctors’ roles in choosing pharmaceuticals, June 2002-May 2003, and May 2006 to June 2007
- Fear of side effects
-
- Figure 6: Attitudes regarding side effects of drugs, by gender, May 2006 to June 2007
- Attitudes to media presentation of side effects
-
- Figure 7: Attitudes regarding the presentation of side effects in D2C advertising, by age, November 2007
Competition from OTC medication
-
- Preferences between OTC and Rx medication
-
- Figure 8: Attitudes toward OTC medicine, by age, May 2006 to June 2007
- Figure 9: Choice of OTC medicine over prescription, by age, November 2007
- Comparison of Rx usage across illnesses in the Internet population
-
- Figure 10: Use of prescription medication, by condition, November 2007
Competition from/Attitudes to Alternative Medicine
-
-
- Figure 11: Attitudes toward alternative medicine, June 2002-May 2003, May 2004-May 2005, May 2006 to June 2007
-
- Figure 12: Attitudes toward alternative medicine, by age, November 2007
-
Attentiveness to Advertising
-
- Introduction
-
- Figure 13: Paying attention to D2C advertising, by type of medication, November 2007
-
- Figure 14: Attentiveness to pharmaceutical ads, by gender, November 2007
-
- Figure 15: Attentiveness to pharmaceutical ads, by age, November 2007
-
- Figure 16: Attentiveness to pharmaceutical ads, by race/ethnicity, November 2007
-
- Figure 17: Attentiveness to pharmaceutical ads, by student status, November 2007
- Why ads are watched
-
- Figure 18: Reasons for watching drug ads, November 2007
-
- Figure 19: Reasons for watching drug ads, by age, November 2007
The Consumer’s Research Process
-
- General health research
-
- Figure 20: Ways of reseaching health information, by gender, May 2006 to June 2007
-
- Figure 21: Ways of researching health information, 2003 vs. 2007
-
- Figure 22: Ways of researching health information, by age, May 2006-June 2007
- Researching healthcare treatments
-
- Figure 23: Researching pharmaceuticals and treatments, 2003 vs. 2007
-
- Figure 24: Researching pharmaceuticals and treatments, by gender, May 2006 to June 2007
Buying Generic vs. Brand Name
-
-
- Figure 25: Attitudes to brand-name drugs, May 2006 to June 2007
-
- Figure 26: Attitudes towards name brand and generic drugs, November 2007
-
- Figure 27: Attitudes towards name brand and generic drugs, by race/ethnicity, November 2007
-
Executive Summary, Part II: Prevalence of Treatment of Specific Conditions
-
- Use of Rx medication varies based on effectiveness of OTC treatment
- Substantial opportunity exists in overweight/obesity and herpes
- Potential for viral marketing apparent
- Depression category leads in sales, sleep aids in ad spend
- Sexual dysfunction is not gender-specific
- Some suffering from allergies not aware that they have them
- Psychiatric medications continue to face obstacles
- A large body of sufferers is not being treated in every condition
- Making men comfortable talking about depression
- Where does trouble concentrating end and ADHD begin?
- Bulleted check list for websites
Prevalence of Conditions and Use of Rx Treatments
-
- Introduction
-
- Figure 28: Prevalence of ailments trended and percentage with ailments using prescription medication, 2003-07
- Substantial opportunity in drugs to combat obesity
- Prescription drug use for allergies declining
- Emphasis on responsibility should grow herpes market
- Depression: Penetration says more about the competition than about the drug
- Internet population
-
- Figure 29: Ailments, have, have had, or friend or family has, November 2007, and May 2006 to june 2007
- Comparison of Rx usage across conditions
-
- Figure 30: Use of prescription medication by condition, November 2007 (GF) and May 2006-June 2007 (NCS)
- Prevalence of conditions suffered in Internet population by demographics
-
- Figure 31: Conditions suffered (self-reported), by age, November 2007
- Figure 32: Conditions suffered (self-reported), by gender, November 2007
-
- Figure 33: Conditions suffered (self-reported), by household income, November 2007
- Figure 34: Conditions suffered (self-reported), by race/Hispanic origin, November 2007
Sales and Advertising Spend
-
- Sales
-
- Figure 35: Sales of 20 leading pharmaceutical products for six conditions, 2004 and 2006
- Depression medication sales
- ADHD medication
- Allergy medications
- Sleep medications
-
- Figure 36: Ad spend on sleep medication, 2005 and 2006
Sexual Dysfunction
-
- Introduction
-
- Figure 37: Suffer or have suffered from sexual dysfunction, by demographic, November 2007
- Treatment of sexual dysfunction
-
- Figure 38: Sexual dysfunction treatment used, by household income, November 2007
- Sexual dysfunction medications
- Viagra
-
- Figure 39: Pfizer Viagra Advertisement
- Levitra
-
- Figure 40: Bayer Levitra Advertisement
- Cialis
-
- Figure 41: Lilly Cialis Advertisement
Pollen Allergies
-
- Introduction
-
- Figure 42: Suffered from nasal allergies/hay fever in last 12 months, by demographic, May 2006 to June 2007
- Treatment of allergies
-
- Figure 43: Nasal allergy treatment used, by age, November 2007
-
- Figure 44: Allergy treatment used, by race/Hispanic origin, November 2007
- Notes on OTC treatment
- Allergy shots
- Nasal airway surgeries
- Allergy medications
- Nasonex
-
- Figure 45: Schering-Plough Nasonex Advertisement
- Allegra
- Clarinex
- Flonase
Overweight and Obesity
-
- Introduction
-
- Figure 46: Prevalence of being 30 pounds overweight in the last 12 months, by key demographics, May 2006 to June 2007
- Xenical
- Competition from gastric bypass surgery
Attitudes Towards Sleep Aids and Psychiatric Drugs
-
-
- Figure 47: Attitudes towards psychiatric illnesses and drugs and sleep aids, November 2007
-
Depression
-
- Introduction
- Prevalence and treatment with Rx medication by demographic
-
- Figure 48: Incidence of depression, and Rx treatment, by demographic, November 2007, and May 2006-June 2007
- Rx vs. other methods of treatment
-
- Figure 49: Depression treatment used, by age, November 2007
- Figure 50: Depression treatment used, by race/ethnicity, November 2007
- Switching depression medication
-
- Figure 51: Reasons to change depression medication, by age, November 2007
- Depression medications
- Effexor
-
- Figure 52: Effexor advertisement
- Zoloft
- Wellbutrin
- Cymbalta
-
- Figure 53: Eli Lilly Cymbalta Advertisement
Anxiety
-
- Introduction
-
- Figure 54: Suffer or have suffered from general or social anxiety, by demographic, November 2007, and May 2006-June 2007
- Treatment of general anxiety
-
- Figure 55: General anxiety treatment used, by age, November 2007
- Treatment of social anxiety
-
- Figure 56: Social anxiety treatment used, by race/ethnicity, November 2007
- Switching anxiety medication
-
- Figure 57: Reasons to change anxiety medication, November 2007
Adhd
-
- Prevalence
-
- Figure 58: Suffers or has suffered from ADHD or trouble concentrating, by age, November 2007
- Treatment of ADHD
-
- Figure 59: ADHD treatment used, by age, November 2007
- ADHD medications
- Concerta
- Adderall XR
- Strattera
Sleep Disorders
-
- Introduction
-
- Figure 60: Suffered from sleep disorders in last 12 months, by age and gender, May 2006 to June 2007, and November 2007
- Treatment of sleep-related problems
-
- Figure 61: Sleep-related problem treatment used, by gender, November 2007
-
- Figure 62: Sleep disorder treatment used, by age, November 2007
- Treatments for sleep apnea
- Sleep disorder medications
- Lunesta
-
- Figure 63: Sepracor Lunesta Advertisement
- Ambien
-
- Figure 64: Sanofi-Aventis Ambien CR Advertisement
- Figure 65: Sanofi-Aventis Ambien CR Advertisement
- Rozerem
- Requip
-
- Figure 66: GlaxoSmithKline Requip Advertisement
Appendix: Trade Associations
Back to top